Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,842 | -8,564 | -6,912 | -4,802 | -2,006 |
| Depreciation Amortization | 173 | 1,039 | 867 | 696 | 408 |
| Accounts payable and accrued liabilities | 708 | -146 | 1,408 | 1,074 | 433 |
| Other Working Capital | 726 | 32 | 1,638 | 975 | 403 |
| Other Operating Activity | -728 | -138 | -1,257 | -904 | -795 |
| Operating Cash Flow | $-962 | $-7,776 | $-4,256 | $-2,961 | $-1,557 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -242 | -225 | -93 | -30 |
| Investing Cash Flow | $-37 | $-242 | $-225 | $-93 | $-30 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 7,082 | 15,100 | 15,100 | 15,100 | 15,100 |
| End Cash Position | 6,082 | 7,082 | 10,618 | 12,046 | 13,512 |
| Net Cash Flow | $-999 | $-8,018 | $-4,482 | $-3,053 | $-1,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -962 | -7,776 | -4,256 | -2,961 | -1,557 |
| Capital Expenditure | -37 | -242 | -225 | -93 | -30 |
| Free Cash Flow | -1,000 | -8,018 | -4,482 | -3,053 | -1,587 |